DL-AP4 - Search Results | AbMole BioScience

About 6 results found for searched term "DL-AP4" (0.126 seconds)

Cat.No.	Name	Target
M6678	DL-AP4	Others
	DL-AP4 is a broad spectrum EAA antagonist.
M6679	DL-AP4 Sodium salt	Others
	DL-AP4 Sodium salt is a broad spectrum EAA antagonist. Sodium salt of DL-AP4.
M57046	DL-AP4	Others
	DL-AP4 (2-Amino-4-phosphonobutyric acid) is a glutamate antagonist.
M24544	Enavatuzumab	TNF Receptor
	PDL192; ABT-361
	Enavatuzumab (PDL192; ABT-361) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab can actively recruits and activates myeloid effectors to kill tumor cells.
M30111	ABT-100	Farnesyl Transferase
	ABT-100 is a potent, highly selective and orally active farnesyltransferase inhibitor. ABT-100 inhibits cell proliferation (IC50s of 2.2 nM, 3.8 nM, 5.9 nM, 6.9 nM, 9.2 nM, 70 nM and 818 nM for EJ-1, DLD-1, MDA-MB-231, HCT-116, MiaPaCa-2, PC-3, and DU-145 cells, respectively), increases apoptosis and decreases angiogenesis. ABT-100 possesses broad-spectrum antitumor activity.
M40817	Polyethylenimine Linear (MW 40000, liquid)	Cell Transfection
	Polyethylenimine Linear (PEI) is a broadly applicable cationic polymer transfection reagent with a molecular weight of 40,000 that forms a complex with nucleic acids and allows the complex to enter mammalian cells.